ADOLESCENT;
ADULT;
ANTIBODY SCREENING;
ARTICLE;
BLOOD COLLECTION TUBE;
BLOOD FILTER;
BLOOD SAMPLING;
CAPILLARY BLOOD;
CHILD;
DRIED BLOOD SPOT TESTING;
FEASIBILITY STUDY;
FEMALE;
HUMAN;
MALE;
PRIORITY JOURNAL;
QUESTIONNAIRE;
RELATIVE;
SENSITIVITY AND SPECIFICITY;
VENOUS BLOOD;
ANTAGONISTS AND INHIBITORS;
BLOOD;
CLINICAL TRIAL;
DIABETES MELLITUS, TYPE 1;
EUROPE;
FAMILY HEALTH;
IMMUNOLOGY;
MASS SCREENING;
MULTICENTER STUDY;
NORTH AMERICA;
PANCREAS ISLET;
PATIENT PREFERENCE;
PROCEDURES;
YOUNG ADULT;
ADOLESCENT;
ADULT;
AUTOANTIBODIES;
CATION TRANSPORT PROTEINS;
CHILD;
DIABETES MELLITUS, TYPE 1;
DRIED BLOOD SPOT TESTING;
EUROPE;
FAMILY HEALTH;
FEASIBILITY STUDIES;
FEMALE;
GLUTAMATE DECARBOXYLASE;
HUMANS;
INSULIN ANTIBODIES;
ISLETS OF LANGERHANS;
MALE;
MASS SCREENING;
NORTH AMERICA;
PATIENT PREFERENCE;
RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 8;
SENSITIVITY AND SPECIFICITY;
YOUNG ADULT;
Psychological impact of childhood islet autoantibody testing in families participating in the BABYDIAB study
Hummel M, Ziegler AG, Roth R: Psychological impact of childhood islet autoantibody testing in families participating in the BABYDIAB study. Diabet Med 2004;21:324-328.
Capillary whole-blood measurement of islet autoantibodies
Costa A, Conget I, Casamitjana R: Response to Bazziga-luppi et al.: Capillary whole-blood measurement of islet autoantibodies. Diabetes Care 2000;23:874.
A simple screening method for individuals at risk of developing type 1 diabetes: Measurement of islet cell autoantibodies (GADA, IA-2A, and IAA) on dried capillary blood spots collected on a filter paper
Siraj ES, Rogers DG, Gupta MK, et al.: A simple screening method for individuals at risk of developing type 1 diabetes: measurement of islet cell autoantibodies (GADA, IA-2A, and IAA) on dried capillary blood spots collected on a filter paper. Horm Metab Res 2013;44:855-860.
The TrialNet natural history study of the development of type 1 diabetes: Objectives, design, and initial results
Mahon JL, Sosenko JM, Rafkin-Mervis L, et al.: The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results. Pediatr Diabetes 2009;10:97-104.
Type 1 Diabetes-TrialNet Study Group: Natural History Study of the Development of Type 1 Diabetes (Protocol TN-01) accessed April 13, 2015
Type 1 Diabetes-TrialNet Study Group: Natural History Study of the Development of Type 1 Diabetes (Protocol TN-01). https://www.diabetestrialnet.org/documents/ancillary/PTP ProtocolSynopsis&SpecimenCollectionSchedule-Protocol V15Aug11.pdf (accessed April 13, 2015).
7
77954949830
Harmonization of glutamic acid decarboxylase and islet antigen-2 autoanti-body assays for National Institute of Diabetes and Digestive and Kidney Diseases Consortia
Bonifacio E, Yu L, Williams AJK, et al.: Harmonization of glutamic acid decarboxylase and islet antigen-2 autoanti-body assays for National Institute of Diabetes and Digestive and Kidney Diseases Consortia. J Clin Endocrinol Metab 2010;95:3360-3367.
Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical auto-antibodies
Yu L, Boulware DC, Beam CA, et al.: Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical auto-antibodies. Diabetes Care. 2012;35:1213-1218.